Prelude Capital Management’s C4 Therapeutics CCCC Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-17,749	Closed	-$100K	–	1220
2023 Q4	$100K	Sell	17,749 -33,400	-65%	-$189K	0.01%	896
2023 Q3	$95.1K	Buy	51,149 +17,149	+50%	+$31.9K	0.01%	858
2023 Q2	$93.5K	Buy	+34,000	New	+$93.5K	0.01%	821